These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26453059)

  • 1. Ex vivo addition of fibrinogen concentrate improves the fibrin network structure in plasma samples taken during liver transplantation.
    Groeneveld DJ; Adelmeijer J; Hugenholtz GC; Ariëns RA; Porte RJ; Lisman T
    J Thromb Haemost; 2015 Dec; 13(12):2192-201. PubMed ID: 26453059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.
    Hugenholtz GC; Macrae F; Adelmeijer J; Dulfer S; Porte RJ; Lisman T; Ariëns RA
    J Thromb Haemost; 2016 May; 14(5):1054-66. PubMed ID: 26833718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates.
    Blasi A; Patel VC; Spanke ENHE; Adelmeijer J; Stamouli M; Zamalloa A; Corcoran E; Calvo A; Fernandez J; Bernal W; Lisman T
    Liver Int; 2022 Feb; 42(2):435-443. PubMed ID: 34894081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of blood clotting characteristics using prothrombin complex concentrate, fibrinogen and FXIII in an albumin based fluid: experimental studies in thromboelastometry.
    Koller T; Kinast N; Castellanos AG; Garcia SP; Iglesias PP; Vintro XL; Arranz JM; Seto NV; García MVM; Moreno-Castaño AB; Aznar-Salatti J; Albaladejo GE; Diaz-Ricart M
    Scand J Trauma Resusc Emerg Med; 2021 Apr; 29(1):57. PubMed ID: 33836790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients.
    Solomon C; Cadamuro J; Ziegler B; Schöchl H; Varvenne M; Sørensen B; Hochleitner G; Rahe-Meyer N
    Transfusion; 2011 Aug; 51(8):1695-706. PubMed ID: 21352237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
    Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Hydroxyethyl Starch Irrelevant to Hemostasis in Patients Undergoing Liver Transplantation?--In vitro Analysis Based on Thromboelastometry.
    Nicińska B; Pluta J; Kołacz M; Łągiewska B; Lisik W; Chmura A; Trzebicki J
    Ann Transplant; 2015 Dec; 20():747-51. PubMed ID: 26675095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease.
    Mills JD; Ariëns RA; Mansfield MW; Grant PJ
    Circulation; 2002 Oct; 106(15):1938-42. PubMed ID: 12370216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Fibrinogen Concentrate on Neonatal Clot Structure When Administered Ex Vivo After Cardiopulmonary Bypass.
    Moiseiwitsch N; Nellenbach KA; Downey LA; Boorman D; Brown AC; Guzzetta NA
    Anesth Analg; 2023 Sep; 137(3):682-690. PubMed ID: 36727748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation and Validation of Maximum Absorbance Data Obtained from Turbidimetry Analysis of Plasma Clots.
    Pieters M; Guthold M; Nunes CM; de Lange Z
    Thromb Haemost; 2020 Jan; 120(1):44-54. PubMed ID: 31752041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.
    Solomon C; Hagl C; Rahe-Meyer N
    Br J Anaesth; 2013 Jun; 110(6):947-56. PubMed ID: 23388508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the structural and mechanical effects of procoagulant agents on neonatal fibrin networks following cardiopulmonary bypass.
    Nellenbach K; Guzzetta NA; Brown AC
    J Thromb Haemost; 2018 Nov; 16(11):2159-2167. PubMed ID: 30182421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry.
    Ogawa S; Szlam F; Bolliger D; Nishimura T; Chen EP; Tanaka KA
    Anesth Analg; 2012 Jul; 115(1):16-21. PubMed ID: 22467887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
    Piechocka IK; Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
    J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial.
    Lancé MD; Ninivaggi M; Schols SE; Feijge MA; Oehrl SK; Kuiper GJ; Nikiforou M; Marcus MA; Hamulyak K; van Pampus EC; ten Cate H; Heemskerk JW
    Vox Sang; 2012 Jul; 103(1):25-34. PubMed ID: 22211833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation.
    Leaker MT; Brooker LA; Mitchell LG; Weitz JI; Superina R; Andrew ME
    Transplantation; 1995 Jul; 60(2):144-7. PubMed ID: 7624956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal assessment of non-specific hemostatic agents for apixaban reversal.
    Martin AC; Gouin-Thibault I; Siguret V; Mordohay A; Samama CM; Gaussem P; Le Bonniec B; Godier A
    J Thromb Haemost; 2015 Mar; 13(3):426-36. PubMed ID: 25630710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma.
    Schmidt DE; Halmin M; Wikman A; Östlund A; Ågren A
    Scand J Clin Lab Invest; 2017 Oct; 77(6):397-405. PubMed ID: 28632435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
    He S; Bark N; Wang H; Svensson J; Blombäck M
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):24-9. PubMed ID: 19129740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.